{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:01:46Z","timestamp":1770969706803,"version":"3.50.1"},"reference-count":20,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The classification and prognosis determination in acute leukemia (AL) are complex and it is unclear what testing is being performed in practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To survey physicians describing their current practice of test ordering in the diagnosis of AL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>In anticipation of a guideline by the College of American Pathologists (CAP) and the American Society for Hematology on laboratory testing needed for the initial workup of AL, a baseline survey was designed by an expert panel from CAP. Members of professional societies were asked to describe their current practice of test ordering.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Two hundred ninety-four responses were received with 258 respondents analyzed after the first qualifying survey question regarding initial diagnosis of AL. One hundred seventy-six of 249 respondents (70.7%) were board-certified hematopathologists. Flow cytometry and karyotype analysis were routinely performed for acute myeloid leukemia (AML) (99.1% [232 of 234] and 96.2% [225 of 234], respectively) and acute lymphoblastic leukemia (ALL) (98.3% [229 of 233] and 96.6% [225 of 233], respectively). In addition, fluorescence in situ hybridization studies were routinely performed by 81.2% (190 of 234) of respondents for AML and 85.0% (198 of 233) of respondents for ALL; other molecular studies were performed by 78.2% (183) for AML and 54.9% (128) for ALL; immunohistochemistry by 44.9% (105) for AML and 47.6% (111) for ALL; and cytochemistry by 24.8% (58) for AML and 14.2% (33) for ALL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>While flow cytometry and karyotyping are routinely reported as being performed for the diagnosis of AL, there is marked variation in the reporting of testing patterns for other genetic studies, immunohistochemistry, and cytochemistry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2016-0398-cp","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T15:13:13Z","timestamp":1495638793000},"page":"1101-1106","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists"],"prefix":"10.5858","volume":"141","author":[{"given":"Tracy I.","family":"George","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Tworek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole E.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Fatheree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhona J.","family":"Souers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raouf E.","family":"Nakhleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Arber","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of New Mexico, Albuquerque (Dr George); the Department of Pathology, St. Joseph Mercy Hospital, Ann Arbor, Michigan (Dr Tworek); Laboratory and Pathology Quality Center (Mses Thomas and Fatheree) and Statistics Department (Ms Souers), College of American Pathologists, Northfield, Illinois; Department of Laboratory Medicine and Pathology, Mayo Clinic Fl"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"issue":"20","key":"2020081300190205800_i1543-2165-141-8-1101-b01","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2020081300190205800_i1543-2165-141-8-1101-b02","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"5","key":"2020081300190205800_i1543-2165-141-8-1101-b03","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"New Engl J Med"},{"issue":"22","key":"2020081300190205800_i1543-2165-141-8-1101-b04","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"2020081300190205800_i1543-2165-141-8-1101-b05","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"2020081300190205800_i1543-2165-141-8-1101-b06","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"2020081300190205800_i1543-2165-141-8-1101-b07","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.6004\/jnccn.2013.0127","article-title":"Acute myeloid leukemia, version 2.2013","volume":"11","author":"O'Donnell","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"2020081300190205800_i1543-2165-141-8-1101-b08","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2020081300190205800_i1543-2165-141-8-1101-b09","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1309\/AJCPP6LVMQG4LNCK","article-title":"Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia","volume":"143","author":"He","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2020081300190205800_i1543-2165-141-8-1101-b10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10428194.2013.801470","article-title":"Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms","volume":"55","author":"Seegmiller","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2020081300190205800_i1543-2165-141-8-1101-b11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5045\/kjh.2010.45.3.171","article-title":"Clinical utility of FISH analysis in addition to G-banded karyotype in hematologic malignancies and proposal of a practical approach","volume":"45","author":"Kwon","year":"2010","journal-title":"Korean J Hematol"},{"key":"2020081300190205800_i1543-2165-141-8-1101-b12","first-page":"18","article-title":"Introduction and overview of the classification of the myeloid neoplasms","author":"Vardiman","year":"2008","journal-title":"Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed"},{"key":"2020081300190205800_i1543-2165-141-8-1101-b13","first-page":"542","article-title":"Peripheral blood admixture in bone marrow aspirates","volume":"114","author":"Vladimirskaya","year":"1987","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"issue":"8","key":"2020081300190205800_i1543-2165-141-8-1101-b14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00277-012-1431-4","article-title":"Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia","volume":"91","author":"Zhou","year":"2012","journal-title":"Ann Hematol"},{"issue":"5","key":"2020081300190205800_i1543-2165-141-8-1101-b15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"issue":"27","key":"2020081300190205800_i1543-2165-141-8-1101-b16","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1200\/JCO.2013.49.1308","article-title":"Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group","volume":"31","author":"Heerema","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"2020081300190205800_i1543-2165-141-8-1101-b17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias","volume":"121","author":"Care","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"2020081300190205800_i1543-2165-141-8-1101-b18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404188","article-title":"Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)","volume":"20","author":"Boissel","year":"2006","journal-title":"Leukemia"},{"issue":"9","key":"2020081300190205800_i1543-2165-141-8-1101-b19","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2005-09-3640","article-title":"Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study","volume":"107","author":"Cairoli","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2020081300190205800_i1543-2165-141-8-1101-b20","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1182\/blood-2009-09-241075","article-title":"Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML","volume":"115","author":"Pollard","year":"2010","journal-title":"Blood"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/8\/1101\/1447064\/arpa_2016-0398-cp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/8\/1101\/1447064\/arpa_2016-0398-cp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:38:05Z","timestamp":1764790685000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/141\/8\/article-p1101.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,24]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2016-0398-cp","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,24]]}}}